| Early use of tocilizumab in the prevention of adult respiratory failure in SARS‐CoV‐2 infections and the utilization of interleukin‐6 levels in the management SJ Antony, MA Davis, MG Davis, NK Almaghlouth, R Guevara, F Omar, ... Journal of Medical Virology 93 (1), 491-498, 2021 | 31 | 2021 |
| Systemic vasospasms induced by vasopressor therapy resulting in diffuse tissue necrosis and death: a case report and review of the literature MU Arian, C Medina, G Matus, AD Hazari, L Chozet, F Omar Journal of Emergency and Critical Care Medicine, 2021 | | 2021 |
| 682. Is There a Role for the Early Use of Tocilizumab and Interleukin-6 Levels in the Management of SARS-CoV-2 Patients with Early Respiratory Failure? SJ Antony, NK Almaghlouth, MG Davis, MA Davis, R Guevara, N Antony, ... Open Forum Infectious Diseases 7 (Supplement_1), S394-S395, 2020 | | 2020 |
| Early use of tocilizumab in the prevention of adult respiratory failure in SARS-CoV-2 infections and the utilization of interleukin-6 levels in the managementSuresh J Antony1 … MG Davis, NK Almaghlouth, R Guevara, F Omar, F Del Rey, A Hassan, ... | | |
